Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

Avandia linked to greater health risks

Discussion in 'Diabetic Foot & Wound Management' started by Cameron, May 22, 2007.

  1. Cameron

    Cameron Well-Known Member

    Members do not see these Ads. Sign Up.
    New England Journal of Medicine are about to published a review on the health risks associated with Avandia (the biggest-selling diabetes drug in the world). When researchers pooled results of dozens of studies they discovered a 43 percent higher risk of heart attack and a 64 percent greater risk of cardiovascular death.

    It is estimated more than 6 million people worldwide take this drug sold by London-based GlaxoSmithKline PLC since it came on the market eight years ago.

  2. admin

    admin Administrator Staff Member

    Attached is a pdf file of the Australian Diabetes Society position statement on this topic.

    Attached Files:

  3. NewsBot

    NewsBot The Admin that posts the news.

    Reuters are reporting:
    Glaxo says Avandia data comforts, experts unsure
    Tue Jun 5, 2007 6:37 PM ET
  4. admin

    admin Administrator Staff Member

    Here is some intrigue:

    Yahoo! Health are reporting:
    Researcher admits leaking diabetes study
    Full story

Share This Page